Open access · CC-BY
via OpenAlex
Cancer and the gut microbiome: the oncogenic impact of dysbiosis
Durre Aden, Kamlesh Darji, Sufian Zaheer
Surgical and Experimental Pathology · 2026
Abstract
Abstract Gut dysbiosis, defined as an imbalance in the gut microbiota’s composition and function, plays a key role in the development of cancer. It alters microbial diversity, disrupts immune function, weakens the gut barrier, and promotes long-term inflammation, contributing to tumour onset and progression. Contributing factors include diet, stress, disrupted sleep, inactivity, antibiotics, environmental exposures, and changes in host genetics or epigenetics. These factors reduce the production of protective microbial byproducts like short-chain fatty acids (SCFAs) and increase the formation of harmful compounds such as nitrosamines and secondary bile acids. Certain bacteria like Fusobacterium nucleatum , Helicobacter pylori , Escherichia coli (pks+), Bacteroides fragilis , and Streptococcus gallolyticus have been linked to cancer through their ability to cause inflammation, damage DNA, or interfere with immune detection. Based on this understanding, approaches such as probiotics, prebiotics, changes in diet, faecal microbiota transplantation (FMT), and targeted microbial treatments are being explored to restore microbial balance and reduce cancer risk. These findings highlight the microbiome’s role in the carcinogenetic pathway.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s42047-026-00244-5
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Aden, D., Darji, K., & Zaheer, S. (2026). Cancer and the gut microbiome: the oncogenic impact of dysbiosis. <em>Surgical and Experimental Pathology</em>. https://doi.org/10.1186/s42047-026-00244-5
Vancouver
Aden D, Darji K, Zaheer S. Cancer and the gut microbiome: the oncogenic impact of dysbiosis. Surgical and Experimental Pathology. 2026. doi:10.1186/s42047-026-00244-5.
BibTeX
@article{durre2026Cancer,
title = {Cancer and the gut microbiome: the oncogenic impact of dysbiosis},
author = {Durre Aden and Kamlesh Darji and Sufian Zaheer},
journal = {Surgical and Experimental Pathology},
year = {2026},
doi = {10.1186/s42047-026-00244-5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current neuropharmacology 2026
Citation only
Exploring the Gut Microbiome as a Promising Frontier in Alzheimer's Disease Therapy.
Aging Pathobiology and Therapeutics 2025
Open access · CC-BY
Inflammaging and microbiota: the intersection of aging, inflammation, and gut health
Frontiers in Endocrinology 2020
Open access · CC-BY
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
CRC Press eBooks 2024
Citation only
Gut Microbiome Dysbiosis and Cancer Risk
Emerging Trends in Metabolites 2024
Open access · CC-BY
Gut Microbiome Dysbiosis During Metabolic Disorders: Diabetes
Frontiers in Endocrinology 2026
Open access · CC-BY